Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.
Epistemonikos ID: 702d2774a4ef72b3d60345a26a2c7d79fa15bb55
First added on: Sep 03, 2025